The U.S. Food and Drug Administration (FDA) has approved four flavored vapes, just days after a reported pressure campaign from President Donald Trump. The decision, announced on Tuesday, permits the marketing of two menthol and two fruit-flavored vape pods manufactured by the Los Angeles-based brand Glas. This move follows President Trump's criticism of FDA Administrator Marty Makary for not expediting the approval of flavored vape products, as reported by The Wall Street Journal.
Political Context and Concerns
According to sources, Trump sought advice from his advisers regarding the FDA commissioner and the potential importance of flavored vapes to younger Republican voters. Advisers reportedly suggested that Makary could hinder the administration's e-cigarette agenda. The White House has argued that such products can assist adults in quitting smoking. Makary had previously aimed to block fruity flavors to safeguard public health, but discussions with Trump indicated a possible shift in stance.
Approved Products and Technology
The approved Glas vape pods include mango and blueberry flavors, alongside two menthol varieties. The FDA highlighted that Glas's technology requires users to verify their age and identity using a government-issued ID and pair the device with a smartphone via Bluetooth. The device becomes inoperable if separated from the phone, and the app conducts random biometric check-ins to ensure the registered user is operating it. Bret Koplow, acting director of the FDA's Center for Tobacco Products, praised the move as a potential game changer in preventing youth access.
Industry and Expert Reactions
Glas CEO Sean Greenbaum expressed satisfaction with the approval, stating that flavored products can help adult smokers transition away from combustible cigarettes while their technology limits youth access. He emphasized the company's commitment to strict FDA oversight and post-market monitoring. However, health experts remain wary. Dr. Michael Blaha, a cardiologist at Johns Hopkins, noted that flavors like bubble gum, fruit, and candy appeal to young people, potentially driving underage vaping. White House spokesperson Kush Desai criticized the previous administration's crackdown, asserting that the Trump administration bases decisions on evidence and science.
The FDA referred inquiries to the White House for comment. This approval marks a significant shift in U.S. vaping policy, balancing adult smoking cessation benefits against youth health risks.
